MediBeacon
Highly Engaged Employees
Manufacturing · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Theodor-kutzer-ufer 1-3, Mannheim, Baden...Website
www.medibeacon.comRevenue
<$5 MillionIndustry
About MediBeacon
MediBeacon Org Chart
Is MediBeacon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once MediBeacon has new funding data
Check if MediBeacon has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on MediBeacon recently announced quarterly report
Product Launch: Get notified when MediBeacon launches new products
MediBeacon, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at MediBeacon
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if MediBeacon had a recent Job posting/layoffs
Check out if MediBeacon is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined MediBeacon as Masked Content
Find more new buyers
Compare Similar Companies to MediBeacon
Compare insights from companies similar to MediBeacon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
MediBeacon
Company Profile Activity
Activity Insights
MediBeacon is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MediBeacon is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MediBeacon.
MediBeacon financials insights
Gather financial insights about MediBeacon, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$5.1M
Series A
$3.5M
Unspecified
$5M
Private Equity
$22.4M
Series B
$33.6M
Series C
$10M
Debt
$4.6M
Other Financing Round
$30M
MediBeacon Tech Stack
A closer look at the technologies used by MediBeacon
Most Recent Scoops
MediBeacon News & Media
MediBeacon® Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology
NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- INNOVATE CORP.® (NYSE: VATE) (“INNOVATE”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, and an equity method investment of INNOVATE, announced that The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, has nominated the MediBeacon® TGFR™ System for the 2026 Prix Galien USA BMediBeacon® Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device Regulation
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, and an equity method investment of INNOVATE, announced receipt of European Union (EU) CE Mark certification under the EU Medical Device Regulation (MDR) for its TGFR™ Monitor and TGFR™ Reusable Sensor. The certification cTransdermal GFR Article Recognized as One of Five 2025 Editors’ Choice Articles by Journal of the American Society of Nephology (JASN)
ST. LOUIS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, today announced that the peer-reviewed transdermal GFR measurement article published in the Journal of the American Society of Nephrology (JASN) has been recognized as one of five 2025 Editor’s Choice articles.1Transdermal GFR Article Recognized as One of Five 2025 Editors’ Choice Articles by Journal of the American Society of Nephrology (JASN)
ST. LOUIS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, today announced that the peer-reviewed transdermal GFR measurement article published in the Journal of the American Society of Nephrology (JASN) has been recognized as one of five 2025 Editor’s Choice articles.1
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MediBeacon
MediBeacon is a medical technology company that specializes in the development of fluorescent tracer agents and transdermal measurement systems. Their flagship product, the Transdermal GFR System (TGFR), allows for non-invasive monitoring of kidney function through a sensor placed on the skin. The company targets a range of clients including leadin... Read More
